Compare Novartis with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs REKVINA LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS REKVINA LABS NOVARTIS/
REKVINA LABS
 
P/E (TTM) x 81.4 -49.3 - View Chart
P/BV x 2.6 6.7 38.8% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 NOVARTIS   REKVINA LABS
EQUITY SHARE DATA
    NOVARTIS
Mar-21
REKVINA LABS
Mar-18
NOVARTIS/
REKVINA LABS
5-Yr Chart
Click to enlarge
High Rs7706 13,873.9%   
Low Rs5015 10,020.0%   
Sales per share (Unadj.) Rs154.50-  
Earnings per share (Unadj.) Rs8.5-0.1 -6,380.5%  
Cash flow per share (Unadj.) Rs13.4-0.1 -10,092.7%  
Dividends per share (Unadj.) Rs10.000-  
Avg Dividend yield %1.60-  
Book value per share (Unadj.) Rs289.20.7 42,958.9%  
Shares outstanding (eoy) m24.696.03 409.5%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x4.1NM-  
Avg P/E ratio x75.1-39.9 -188.3%  
P/CF ratio (eoy) x47.5-39.9 -119.0%  
Price / Book Value ratio x2.27.8 28.0%  
Dividend payout %118.10-   
Avg Mkt Cap Rs m15,69132 49,346.7%   
No. of employees `000NANA-   
Total wages/salary Rs m1,0850-   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m3,8140-  
Other income Rs m3320 174,736.8%   
Total revenues Rs m4,1460 2,181,842.1%   
Gross profit Rs m267-1 -26,949.5%  
Depreciation Rs m1220-   
Interest Rs m770-   
Profit before tax Rs m400-1 -50,050.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1910-   
Profit after tax Rs m209-1 -26,125.0%  
Gross profit margin %7.0NM- 
Effective tax rate %47.80-   
Net profit margin %5.5NM- 
BALANCE SHEET DATA
Current assets Rs m9,2246 162,385.6%   
Current liabilities Rs m3,5734 90,217.2%   
Net working cap to sales %148.2NM- 
Current ratio x2.61.4 180.0%  
Inventory Days Days176NM- 
Debtors Days Days37NM- 
Net fixed assets Rs m2,4802 106,429.2%   
Share capital Rs m12330 409.4%   
"Free" reserves Rs m7,018-26 -26,909.5%   
Net worth Rs m7,1414 175,896.6%   
Long term debt Rs m00-   
Total assets Rs m11,7038 146,108.6%  
Interest coverage x6.2NM-  
Debt to equity ratio x00-  
Sales to assets ratio x0.30-   
Return on assets %2.4-10.0 -24.5%  
Return on equity %2.9-19.7 -14.9%  
Return on capital %6.7-19.6 -34.0%  
Exports to sales %9.3NM-  
Imports to sales %0NM-  
Exports (fob) Rs m354NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3540-   
Fx outflow Rs m9740-   
Net fx Rs m-6210-   
CASH FLOW
From Operations Rs m-6920 300,913.0%  
From Investments Rs m952NA-  
From Financial Activity Rs m-368NA -102,222.2%  
Net Cashflow Rs m-1090 -83,461.5%  

Share Holding

Indian Promoters % 0.0 31.2 -  
Foreign collaborators % 70.7 0.0 -  
Indian inst/Mut Fund % 0.8 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 29.3 68.8 42.6%  
Shareholders   45,141 2,474 1,824.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   UNITECH INTERN.  SUN RETAIL  PRIYA.  AMIT INTNL.  NARBADA GEMS  



Today's Market

Tech Mahindra Quarterly Results, Tata Power's Milestone of 1,000 EV Charging Stations, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a positive note yesterday. Benchmark indices snapped their 4-day losing streak, led by gains in index heavyweights ICICI Bank, ONGC and Axis Bank.

Related Views on News

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

5 Green Energy Stocks to Watch as India Readies for a Revolution(Views On News)

Oct 13, 2021

The excitement around green energy stocks has opened up a huge contrarian opportunity in the traditional energy space.

Could HDFC Bank be a Big EV Winner? The Answer Will Surprise You...(Profit Hunter)

Oct 13, 2021

Why should investors take it for granted that India's Tesla will be one of the major auto stocks?

Tata Group Stocks are on Fire: Which one Should You Buy?(Profit Hunter)

Oct 15, 2021

Tata group stocks are on fire. Find out which one deserves your attention.

Massive Surge in the Shares of Tata Motors Today. Key Factors Favouring the Rally(Views On News)

Oct 13, 2021

Tata Motors zooms 23% after report of TPG investing Rs 75 bn in EV arm.

India's Big PSU Selloff: Watch Out for these Top Stocks(Views On News)

Oct 15, 2021

The government's plan to divest its stakes in PSUs could spark off a rally in these four stocks.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Oct 25, 2021 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS 8-QTR ANALYSIS

COMPARE NOVARTIS WITH

MARKET STATS